- Home
- RVNC vs IPXX Comparison
RVNC vs IPXX Comparison
Compare RVNC & IPXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- IPXX
- Stock Information
- Founded
- RVNC 1999
- IPXX 2023
- Country
- RVNC United States
- IPXX United States
- Employees
- RVNC N/A
- IPXX N/A
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- IPXX Blank Checks
- Sector
- RVNC Health Care
- IPXX Finance
- Exchange
- RVNC Nasdaq
- IPXX Nasdaq
- Market Cap
- RVNC 320.5M
- IPXX 337.5M
- IPO Year
- RVNC 2014
- IPXX 2023
- Fundamental
- Price
- RVNC $3.09
- IPXX $10.99
- Analyst Decision
- RVNC Hold
- IPXX
- Analyst Count
- RVNC 9
- IPXX 0
- Target Price
- RVNC $8.45
- IPXX N/A
- AVG Volume (30 Days)
- RVNC 3.6M
- IPXX 14.0K
- Earning Date
- RVNC 11-07-2024
- IPXX 01-01-0001
- Dividend Yield
- RVNC N/A
- IPXX N/A
- EPS Growth
- RVNC N/A
- IPXX N/A
- EPS
- RVNC N/A
- IPXX 0.37
- Revenue
- RVNC $256,945,000.00
- IPXX N/A
- Revenue This Year
- RVNC $11.28
- IPXX N/A
- Revenue Next Year
- RVNC $27.21
- IPXX N/A
- P/E Ratio
- RVNC N/A
- IPXX $29.42
- Revenue Growth
- RVNC 25.82
- IPXX N/A
- 52 Week Low
- RVNC $2.30
- IPXX $10.31
- 52 Week High
- RVNC $9.75
- IPXX $15.18
- Technical
- Relative Strength Index (RSI)
- RVNC 33.47
- IPXX 44.61
- Support Level
- RVNC $3.06
- IPXX $10.76
- Resistance Level
- RVNC $3.09
- IPXX $15.18
- Average True Range (ATR)
- RVNC 0.11
- IPXX 0.86
- MACD
- RVNC 0.02
- IPXX -0.16
- Stochastic Oscillator
- RVNC 6.90
- IPXX 5.23
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.
About IPXX Inflection Point Acquisition Corp. II
Inflection Point Acquisition Corp II is a blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.